Fixstars Joins the AWS Japan Generative AI Practical Application Promotion Program

Fixstars AI Booster to Support AWS Users in AI Model Development Fixstars Corporation, a global leader in AI-driven software development and acceleration, today announced its participation in the “AWS Japan Generative AI Practical Application Promotion Program,” provided by Amazon Web Services (AWS) Japan G.K. Through this program, Fixstars will offer its AI acceleration platform, “Fixstars […]

Fairfax City Economic Development Offers $25,000 to Boost Small Business Marketing

Fairfax City Economic Development (FCED) has launched the Fairfax City Business Marketing Grant, a funding initiative designed to support businesses located and operating in Fairfax City. The program offers financial support for professional marketing services to help businesses improve visibility, foster growth, and strengthen their competitiveness in the market. https://mma.prnewswire.com/media/2429294/FairfaxCity_EDA_Brand_Horizontal_LogoV1.jpg Fairfax City Economic Development launches

The National Police Association Supports Legislation Introduced by Sen. Jim Banks and Rep. Virginia Foxx to Protect Officers from Lawfare

The National Police Association (NPA) supports the Qualified Immunity Act of 2025, a crucial piece of legislation that would once and for all codify the vital protections our police officers require to do their jobs without fear of frivolous lawsuits. Since 1967, the U.S. Supreme Court has recognized and upheld the Qualified Immunity Doctrine, providing

Front Line Medical Technologies Expands Life-Saving REBOA Device, COBRA-OSĀ®, to the UK Healthcare Market

Next Generation Aortic Occlusion Technology Enters UK Healthcare System Front Line Medical Technologies, a leader in innovative medical devices for emergency and trauma care, announces the UK launch of its CE-marked COBRA-OS®, the world's smallest aortic occlusion device, designed to save lives by rapidly controlling critical bleeding. The COBRA-OS® has received approval for sale in

To Combat Mounting Cargo Theft, Verisk Launches CargoNet(R) RouteScore API

(NASDAQ:VRSK), JERSEY CITY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) — Cargo theft losses in the U.S. continue to climb: 2024 is projected to record 25 percent more losses than 2023, a year that also reached all-time highs for reported incidents. Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today launched CargoNet(R) RouteScore

Communiqué from Boliden’s Extraordinary General Meeting

Boliden's Extraordinary General Meeting was held on January 23, 2025 live in Stockholm and through postal voting. Resolution on authorization for the Board of Directors to resolve on new share issues The Meeting resolved, in accordance with the Board of Directors' proposal, to authorize the Board of Directors to, on one or more occasions during

Sword Health Acquires Surgery Hero to Accelerate Global Growth and Expand its Presence in the UK

New York & London, Jan. 23, 2025 (GLOBE NEWSWIRE) — Sword Health, a global leader in AI Care, making world-class, life-changing care accessible anytime, anywhere, today announced its acquisition of Surgery Hero, a UK-based innovator in prehabilitation digital health. This acquisition bolsters Sword's investment in the UK, where the National Health Service (NHS) faces the

NCRA celebrates passage of Michigan HB 5046

Reston, VA, Jan. 23, 2025 (GLOBE NEWSWIRE) — The National Court Reporters Association (NCRA), the country's leading organization representing stenographic court reporters, captioners, and legal videographers, proudly applauds the Michigan legislature for the successful passage of House Bill 5046, and Gov. Gretchen Whitmer for signing the measure on January 17. HB 5046 gained bipartisan support

Tiziana Life Sciences not to engage in capital raising activities for the immediate future

(NASDAQ:TLSA), NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces its intention not to engage in a capital raising activities for the immediate future.

Mavsign and RouteOne Integrate to Streamline Automotive Transactions

Mavsign, a leader in automotive remote ID verification, offsite closing, and fraud prevention solutions, has launched the first phase of its integration with RouteOne. This groundbreaking integration transforms the vehicle transaction process by integrating RouteOne's finance and insurance platform with Mavsign's advanced remote signing and verification capabilities, delivering unparalleled efficiency and security. https://mma.prnewswire.com/media/2604446/banner_routeone_mavsign_final.jpg Dealerships can

Scroll to Top